Corrigendum to “Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson’s disease” [Cell. Immunol. 327 (2018) 77–82]

M.N. Karpenko,A.A. Vasilishina, E.A. Gromova,Z.M. Muruzheva,A. Bernadotte

Cellular Immunology(2018)

引用 4|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要